Treatment of Shingles in Infants
Infants diagnosed with shingles should be treated with oral acyclovir at 20 mg/kg body weight (maximum 400 mg/dose) three times daily for 5-10 days, ideally started within 24 hours of rash onset. 1
First-Line Antiviral Treatment
- Oral acyclovir is the primary treatment recommended by the CDC for shingles in immunocompetent children, including infants 1
- The standard dosing is acyclovir 20 mg/kg body weight (maximum 400 mg/dose) orally 3 times daily for 5-10 days 1
- Treatment must be initiated within 24 hours of rash onset to maximize effectiveness 1, 2
- Early antiviral therapy shortens viral shedding, accelerates healing by 1-2 days, and reduces the intensity and duration of acute pain 3
When to Escalate to Intravenous Therapy
For severe cases or immunocompromised infants, intravenous acyclovir is necessary:
- IV acyclovir dosing: 10 mg/kg body weight every 8 hours 1, 2
- This route is indicated for disseminated disease, visceral involvement, or any immunocompromised state 1, 4
- Immunocompromised infants are at high risk for severe complications including viral pneumonia, encephalitis, and hepatitis 4
Critical Considerations for Infants
Shingles in infancy warrants special attention:
- Infants who acquired chickenpox during their first year of life have an increased risk of developing shingles 5
- While shingles is rare in children overall, when it occurs in infants, the diagnosis is primarily clinical based on the characteristic unilateral dermatomal vesicular rash 6
- If history and physical examination are normal, laboratory testing for occult immunodeficiency or malignancy is not necessary 6
- However, nine out of 25 pediatric cases in one series were immunocompromised, highlighting the importance of considering underlying conditions 6
Adjunctive Management
Beyond antivirals, supportive care includes:
- Antiseptic measures to prevent secondary bacterial infection 6
- Analgesics for pain control as needed 6
- Antibiotics only if secondary bacterial infection develops 6
Prevention in Susceptible Infants
For infants exposed to varicella-zoster virus who have never had chickenpox:
- Varicella zoster immune globulin (VZIG) should be administered within 96 hours of exposure (ideally within 48 hours) 5, 1
- VZIG dosing: 1 vial (1.25 mL) per 10 kg body weight intramuscularly (maximum 5 vials) 5
- If VZIG is unavailable, consider a 7-day course of oral acyclovir started 7-10 days after exposure 2
Common Pitfalls to Avoid
- Do not delay treatment initiation, especially in high-risk infants 2
- Do not withhold antiviral therapy while awaiting laboratory confirmation—the diagnosis is clinical 6
- Do not assume a benign course in immunocompromised infants, as they require aggressive IV treatment 1, 4
- Chronic suppressive therapy is not needed after lesions resolve 2